Cwm LLC Buys 1,168 Shares of CVS Health Co. (NYSE:CVS)

Cwm LLC increased its stake in CVS Health Co. (NYSE:CVS) by 1.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 72,073 shares of the pharmacy operator’s stock after acquiring an additional 1,168 shares during the period. Cwm LLC’s holdings in CVS Health were worth $5,691,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. 1900 Wealth Management LLC bought a new position in CVS Health during the 3rd quarter valued at approximately $219,000. Exchange Traded Concepts LLC raised its position in CVS Health by 22.8% during the 3rd quarter. Exchange Traded Concepts LLC now owns 5,993 shares of the pharmacy operator’s stock valued at $418,000 after purchasing an additional 1,112 shares during the last quarter. Private Trust Co. NA raised its position in CVS Health by 21.9% during the 3rd quarter. Private Trust Co. NA now owns 17,253 shares of the pharmacy operator’s stock valued at $1,205,000 after purchasing an additional 3,103 shares during the last quarter. Riverwater Partners LLC raised its position in CVS Health by 24.3% during the 3rd quarter. Riverwater Partners LLC now owns 4,205 shares of the pharmacy operator’s stock valued at $294,000 after purchasing an additional 821 shares during the last quarter. Finally, LaFleur & Godfrey LLC raised its position in CVS Health by 1.2% during the 3rd quarter. LaFleur & Godfrey LLC now owns 29,806 shares of the pharmacy operator’s stock valued at $2,081,000 after purchasing an additional 345 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on CVS. Royal Bank of Canada reduced their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Cantor Fitzgerald reiterated an “overweight” rating and set a $87.00 target price on shares of CVS Health in a report on Wednesday, April 10th. SVB Leerink began coverage on CVS Health in a report on Monday, February 26th. They set an “outperform” rating and a $88.00 target price on the stock. Barclays began coverage on CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 target price on the stock. Finally, Piper Sandler upped their target price on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $89.44.

Insiders Place Their Bets

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.24% of the company’s stock.

CVS Health Stock Down 1.6 %

CVS Health stock opened at $68.50 on Wednesday. The firm has a market cap of $86.34 billion, a price-to-earnings ratio of 10.60, a PEG ratio of 0.92 and a beta of 0.52. The stock has a fifty day simple moving average of $74.97 and a two-hundred day simple moving average of $73.76. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The business had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.99 EPS. Equities analysts predict that CVS Health Co. will post 8.31 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.88%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.